Taylor et al. [110] demonstrated CTLA-4 and PD-1 blockade, combined with adoptive cell therapy, significantly delayed tumor growth and prolonged survival by stringently depleting Treg cells in TNBC murine models. The gene discussed is CTLA4; the disease is neoplasm.